Kingdom Capital
Kingdom Capital is a venture capital firm established in 2016, headquartered in Chesterfield, Missouri. It focuses on investing in early-stage, growth-stage, and mature companies across healthcare, technology, media, and real estate sectors.
Top Stages
https://crunchbase.com/organization/***
https://linkedin.com/company/***
Past deals in Missouri
Canopy Biosciences
Series A in 2018
Canopy Biosciences, founded in 2016 and headquartered in St. Louis, Missouri, is a biotechnology company specializing in research tools for genetic engineering, molecular biology, and personalized medicine. The company offers a comprehensive range of products and services designed to facilitate gene editing, gene expression analysis, and bioprocessing. One of its key technologies, TUNR, targets translation elongation by inserting polyA tracks into specific coding regions of the genome, effectively reducing mRNA levels and suppressing protein expression. This innovative approach supports biomedical researchers at universities, research institutions, and within the biotechnology and pharmaceutical sectors, accelerating scientific discovery and enhancing the field of genetic engineering. Canopy Biosciences operates as a subsidiary of Bruker Corporation.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.